September 9, 2019
Taiho Pharmaceutical said on September 6 that its French partner Servier has earned European regulatory approval for Lonsurf (trifluridine + tipiracil) for an additional indication of previously treated metastatic gastric cancer. The European Commission approved Lonsurf as a monotherapy for...read more